Survival to hospital discharge from out-of-hospital cardiac arrest remains poor. Although there are many possible reasons for this, efforts to uncover and address each factor may subsequently lead to improved outcomes. In this issue of Circulation, Valenzuela and colleagues evaluate whether frequent interruptions of chest compression during the resuscitation period may contribute to low survival rates. In an analysis of automated external defibrillator-equipped fire department first responders, the authors investigate the precise timing of the delivery of automated external defibrillator shock from the 9-1-1 call and the percentage of time that chest compressions were performed during 61 cardiac arrests. Their surprising findings highlight the need for a greater focus on cardiopulmonary resuscitation performance as part of the resuscitation effort. See p 1259.
IMPACT OF A SINGLE INTRAVENOUS ADMINISTRATION OF NICORANDIL BEFORE REPERFUSION IN PATIENTS WITH ST-SEGMENT-ELEVATION MYOCARDIAL INFARCTION, by Ishii et al.
Nicolandil is a hybrid between nitrates and KATP channel opener. Nicolandil has venodilating properties due to nitrate group in its chemical structure and causes smooth muscle relaxation and subsequent vasodilation by increasing potassium flux through sarcolemma ATP-sensitive potassium channels. Therefore, the drug acts as a balanced arterial dilator and venodilator. Unlike classical nitrates, hemodynamic tolerance to nicolandil has been reported to be negligible. The potassium channel activation also exerts direct cardioprotective effects by activating ectosolic 5'-nucleotide and mimicking ischemic preconditioning. Infarct-limiting effects of nicolandil have been shown in a number of animal models. Nicolandil has been studied extensively in many patients with ischemic heart disease, both in placebo-controlled studies and in comparative studies with other antiischemic agents. Efficacy of intravenous nicolandil in conjunction with coronary angioplasty has also been reported repeatedly. This study offers additional evidence of persistent cardioprotective effects of single intravenous administration of nicolandil not only in the early stage but also in the chronic stage after reperfusion therapy in ST-segment-elevation myocardial infarction. Further studies will be needed to determine optimal doses and timing and method of injection. See p 1284.
C-REACTIVE PROTEIN AS A PREDICTOR OF CARDIOVASCULAR RISK IN A POPULATION WITH A HIGH PREVALENCE OF DIABETES: THE STRONG HEART STUDY, by Best et al.
C-reactive protein (CRP) has been related to a wide array of cardiovascular disease outcomes, including peripheral arterial disease, stroke, myocardial infarction, and mortality. However, most of the research examining the prognostic utility of CRP has been based on predominantly white North American or Western European study samples. There has been a paucity of data on the prognostic performance of CRP in ethnic/racial minorities. Best and colleagues from the Strong Heart Study examined the relation of CRP to prognosis in more than 3200 American Indians. The prevalence of obesity and diabetes in the cohort was high, at Ն50%. The CRP levels were higher than reported from most other studies, and 16% of participants exceeded 10 mg/L. The investigators noted that although CRP was predictive of cardiovascular disease, there was wide heterogeneity in its predictive ability by subgroup. For instance, CRP was not prognostically useful in their participants with diabetes. The study emphasizes that risk factors must be validated and calibrated in other ethnicities/races and settings before being widely utilized. See p 1289.
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